首页 | 本学科首页   官方微博 | 高级检索  
检索        

叠氮胸苷对胶质母细胞瘤细胞系TJ905细胞p33ING1b表达和细胞衰老及凋亡的影响
作者姓名:Wang Q  Yu SZ  Zhao WJ  Liu J  Sun CY  An TL  Wang LL  Ren XL  Chen XJ
作者单位:天津医科大学总医院 天津市神经病学研究所神经病理研究室 天津市神经损伤变异与再生重点实验室 教育部中枢创伤修复与再生重点实验室,300052
基金项目:国家973计划分项目,国家自然科学基金,教育部高等学校博士学科点专项科研基金,天津市科技攻关计划重点项目,天津市科技支撑计划重点项目,天津市应用基础及前沿技术研究计划重点项目,天津市高等学校科技发展基金重点项目,天津市高等学校科技发展基金 
摘    要:目的 观察叠氮胸苷对恶性胶质瘤细胞系TJ905细胞p33ING1b表达的影响及该影响与细胞凋亡和衰老的关系.方法 将体外培养的TJ905细胞系分为对照组,50、100及200 μmol/L叠氮胸苷组,在后三组的培养液中分别给予相应终浓度的叠氮胸苷并继续传代培养;各组取第1、3、6代细胞以半定量逆转录聚合酶链反应(RT-PCR)和衰老相关β-半乳糖苷酶染色检测p33ING1bmRNA表达水平及衰老细胞;取第3、6代细胞以TUNEL法和单细胞凝胶电泳法检测凋亡细胞.结果 从用药后第1代起叠氮胸苷即呈时间和剂量依赖性地诱导TJ905细胞p33ING1b mRNA表达和细胞衰老;200 μmol/L叠氮胸苷组第6代TJ905细胞的p33ING1b RT-PCR扩增条带相对灰度(1.44±0.23)显著高于同组第1代(0.95±0.13)、第3代(1.35±0.23)及同代50μmol/L组(0.85±0.24)和100 μmol/L组(1.23±0.34),其衰老相关β-半乳糖苷酶标记指数(45.62±6.74)亦显著高于同组第1代(7.82±2.40)、第3代(26.27±7.17)及同代50 μmol/L组(27.37±6.41)和100 μmol/L组(35.49±5.12),上述差异均有统计学意义(P<0.01);而叠氮胸苷促凋亡作用出现在稍晚的第6代.结论 叠氮胸苷可上调TJ905细胞p33ING1b的表达水平,这可能是叠氮胸苷诱导TJ905细胞衰老和凋亡的重要分子机制.

关 键 词:神经胶质瘤  齐多夫定  细胞衰老  细胞凋亡  细胞系  肿瘤

Effects of azidothymidine on p33ING1b expression, apoptosis and senescence of TJ905 human glioblastoma cell line
Wang Q,Yu SZ,Zhao WJ,Liu J,Sun CY,An TL,Wang LL,Ren XL,Chen XJ.Effects of azidothymidine on p33ING1b expression, apoptosis and senescence of TJ905 human glioblastoma cell line[J].Chinese Journal of Pathology,2010,39(10):686-690.
Authors:Wang Qian  Yu Shi-zhu  Zhao Wen-juan  Liu Jing  Sun Cui-yun  An Tong-ling  Wang Li-li  Ren Xiao-li  Chen Xiu-ju
Institution:Department of Neuropathology, Neurological Institute of Tianjin Medical University General Hospital, Tianjin Key Laboratory of Injuries, Variations and Regeneration of Nervous System, Tianjin 300052, China.
Abstract:Objectives To investigate the pharmacological effects of azidothymidine (AZT) on p33ING1b expression, senescence and apoptosis of TJ905 glioblastoma cells. Methods TJ905 cells were treated with AZT at a serial concentrations of 50, 100 and 200 μmol/L. Semi-quantitative RT-PCR and cytochemical staining of senescence related-galactosidase (sβ-Gal) were used to evaluate the expression of p33ING1b mRNA and to label the senescent cells at the 1st, 3rd and 6th generations, respectively. In situ cell death detection and single cell gel electrophoresis were used to detect the apoptosis at the 3rd and 6th generations. Results AZT induced the expression of p33ING1b mRNA and senescence of the tumor cells of the 1st generation in a dosage and time dependent manner. At the 6th generation, the relative amount of p33ING1b RT-PCR product (1.44 ±0. 23 ) and s3-Gal labeling index of 200 μ mol/L group (45. 62 ±6. 74)were significantly higher than those of the 1st( 0. 95 ± 0. 13 and 7. 82 ± 2. 40 ) and the 3rd generation cells (1.35 ± 0. 23, 26. 27 ± 7. 17 ) of the same group, and cells of the same generation in the 50 μmol/L(0.85 ±0.24, 27.37 ±6.41) and 100 μmol/L groups (1.23 ±0.34, 35.49 ±5.12, P<0.01 ). Therewas a significant positive correlation between the p33ING1b mRNA expression and the labeling index of sβ-Gal. Pro-apoptotic effects of AZT became obvious at the 6th generation. Conclusion AZT upregulates the expression of p33ING1b, a possible mechanism in regulating senescence and apoptosis of the TJ905 cells.
Keywords:Glioma  Zidovudine  Cell aging  Apoptosis  Cell line  tumor
本文献已被 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号